Iowa SF197 mandates insurance coverage for prescription drugs used in treating metastatic cancer and associated conditions.

Iowa SF197 requires policies, contracts, or plans providing third-party payment or prepayment of health or medical expenses to cover prescription cancer drugs for metastatic cancer and associated conditions. The bill applies to certain types of insurance contracts and plans delivered, issued for delivery, continued, or renewed in Iowa on or after January 1, 2026. The coverage must be without imposing a step therapy protocol if the drug is approved by the United States Food and Drug Administration and its use aligns with medical standards of care for metastatic cancer.

Iowa SF197 mandates insurance coverage for prescription drugs used in treating metastatic cancer and associated conditions.

Iowa SF197 requires policies, contracts, or plans providing third-party payment or prepayment of health or medical expenses to cover prescription cancer drugs for metastatic cancer and associated conditions. The bill applies to certain types of insurance contracts and plans delivered, issued for delivery, continued, or renewed in Iowa on or after January 1, 2026. The coverage must be without imposing a step therapy protocol if the drug is approved by the United States Food and Drug Administration and its use aligns with medical standards of care for metastatic cancer.